Welcome to our dedicated page for CHEMUNG FINANCIAL SEC filings (Ticker: CHMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Chemung Financial Corporation filings document the disclosure record of a New York financial services holding company whose common stock trades on Nasdaq under CHMG. Recent Form 8-K reports cover operating results, dividend declarations, Regulation FD investor presentations, capital and balance sheet topics, and other corporate events involving Chemung Canal Trust Company.
The company’s proxy filings describe board governance, shareholder voting matters, executive compensation, equity awards, and pay-versus-performance disclosures. Its SEC reports also record registered common-stock information and bank regulatory matters affecting the structure and oversight of its principal banking subsidiary.
CHEMUNG FINANCIAL CORP Executive Vice President and Chief Credit Officer Peter K. Cosgrove reported a small share disposition related to tax withholding. On February 27, 2026, 119 shares of common stock were withheld at $55.52 per share, leaving him with 7,200 directly owned shares.
Chemung Financial Corp executive Loren D. Cole, EVP & CIO, reported a tax-related share disposition. On February 27, 2026, 119 shares of common stock were surrendered at $55.52 per share to cover tax withholding, leaving 6,398 shares held directly. The filing also notes indirect holdings of 105 shares owned by a spouse and 9,601.981 shares held through a qualified plan, which include dividends periodically issued under the company’s dividend reinvestment plan.
Chemung Financial Corp director Robert H. Dalrymple reported an open-market sale of 2,833 shares of common stock at a price of $56.5591 per share on February 26, 2026. After this sale, he directly holds 1,351 shares and has additional indirect holdings through RD Wood, LLC and his spouse.
CHMG submitted a Form 144 reporting a proposed sale of common stock by an affiliate.
The filing lists Raymond James & Associates as the broker and shows 02/20/2026. The form enumerates multiple prior compensation-related issuances dated 01/19/2021, 01/26/2023, 01/18/2024, and 01/17/2025.
Tomson Anders reported acquisition or exercise transactions in this Form 4 filing.
Chemung Financial Corp President & CEO Tomson Anders reported an award of 4,221 shares of common stock on February 17, 2026 at $59.24 per share. After this grant, he directly held 47,825.938 common shares and indirectly held 17,699.638 shares through a qualified plan.
Chemung Financial Corp reported that its Controller, John J. Stempin, acquired 127 shares of common stock on a grant or award basis. The shares were valued at $59.24 per share. After this grant, his directly held common stock ownership increased to 487 shares.
Chemung Financial Corp reported that EVP and Chief Risk Officer Mary E. Meisner acquired 1,140 shares of common stock as a grant or award at $59.24 per share. Following this award, she directly holds a total of 4,528.448 Chemung Financial common shares.
CHEMUNG FINANCIAL CORP executive Dale M. McKim III, the EVP, CFO & Treasurer, reported an acquisition of common stock through a grant or award. He received 1,773 shares of common stock on February 17, 2026 at a price of $59.24 per share. After this transaction, his directly owned stake increased to 7,080 common shares.
Chemung Financial Corp Regional President Jeffrey P. Kenefick reported an equity award of company stock. On February 17, 2026, he acquired 1,368 shares of common stock as a grant or award at $59.24 per share, increasing his direct holdings to 11,582.763 shares.
He also reports 3,029.606 shares held indirectly through a qualified plan, which includes dividends issued periodically under the issuer’s Dividend Reinvestment Plan. The filing reflects compensation-related share acquisition rather than an open-market purchase or sale.
CHEMUNG FINANCIAL CORP Executive Vice President Kimberly A. Hazelton reported an equity award of 1,056 shares of common stock on February 17, 2026, labeled as a grant, award, or other acquisition at $59.24 per share. Following this grant, her directly held stake increased to 8,266 common shares.